Action FRBN.U FORBION EUROPEAN ACQUISITION CORP.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Forbion European Acquisition Corp. Nasdaq

Actions

FRBN.U

KYG3619H1285

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
EnGene, Inc. completed the acquisition of Forbion European Acquisition Corp. from a group of shareholders in a reverse merger transaction.
Forbion European Acquisition Corp.(NasdaqGM:FRBN) dropped from NASDAQ Composite Index
Wall Street Set to Open Higher Monday as Investors Parse Earnings, Await Fed Meeting
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Wall Street Set to Open Higher Friday; Core Inflation Rises 0.3% Matching Forecast
Top Premarket Decliners
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding
Forbion European Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding from Forbion Growth Sponsor Feac I B.V.
EnGene, Inc. and Forbion European Acquisition Corp. ("FEAC", Nasdaq: FRBN) Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies - Form 8-K
Forbion European Acquisition Corp. entered into a business combination agreement to acquire enGene, Inc from shareholders.
Forbion European Acquisition Corp. announced that it has received $56.891682 million in funding from a group of investors
Forbion European Acquisition Corp. announced that it received $56.891682 million in funding from enGene Holdings, and other investors
Forbion European Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Forbion European Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Forbion European Acquisition Corp. Auditor Raises 'Going Concern' Doubt
Forbion European Acquisition Corp. announced that it expects to receive $0.9 million in funding
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Certain Class B Ordinary Shares of Forbion European Acquisition Corp. are subject to a Lock-Up Agreement Ending on 8-JUN-2022.
Forbion European Acquisition Corp.(NasdaqGM:FRBN) added to NASDAQ Composite Index
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action FRBN
  4. Action FRBN.U
  5. Actualités Forbion European Acquisition Corp.
  6. Autres langues